0 التعليقات
0 المشاركات
1767 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
- الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
- Bioprocess Validation Market is Estimated To Witness High Growth Owing To Increasing Demand Of Monoclonal Antibodies for Chronic DiseasesThe Bioprocess Validation Market is estimated to be valued at US$ 356.8 Mn in 2023 and is expected to exhibit a CAGR of 11.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Bioprocess validation includes confirming that any procedure, process, equipment, material, activity or system leads to the expected results. It...0 التعليقات 0 المشاركات 1733 مشاهدة 0 معاينة
- Bioreactors Market is poised to Witness High Growth due to Rising Demand for Monoclonal AntibodiesThe bioreactors market revolves around products utilized for carrying out reactions that involve biological components such as microorganisms, enzymes, or cells. Bioreactors find widespread usage in biotechnology and pharmaceutical industries for manufacturing biotherapeutics, vaccines, and antibiotics. They provide controlled environmental conditions essential for cell and tissue growth, which...0 التعليقات 0 المشاركات 192 مشاهدة 0 معاينة
- Cancer Monoclonal Antibodies Market Global Trends Forecast 2022-28The global cancer monoclonal antibodies market size was valued at USD 47.2 billion in 2021 and is poised to grow at a significant CAGR of 11.8% during the forecast period 2022-28. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on “Cancer Monoclonal Antibodies Market: By...0 التعليقات 0 المشاركات 2043 مشاهدة 0 معاينة
- Cancer Monoclonal Antibodies Market Size, Analysis and Forecast 2031The Cancer Monoclonal Antibodies Market in 2023 is US$ 89.23 billion, and is expected to reach US$ 354.52 billion by 2031 at a CAGR of 18.80%. FutureWise Research published a report that analyzes Cancer Monoclonal Antibodies Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure....0 التعليقات 0 المشاركات 1312 مشاهدة 0 معاينة
- Cancer Monoclonal Antibodies Market Size, Share, Emerging Trends and Overview 2030The report " Cancer Monoclonal Antibodies Market by Application (Breast Cancer, Blood Cancer, Liver Cancer, Brain cancer, Colorectal Cancer, Other), by Type of Antibody (Murine Antibodies, Humanized Antibodies, Chimeric Antibodies), by Conjugation (Immunocytokines, Immunoliposome, Radioimmunotherapy, Antibody Directed Enzyme Prodrug Therapy (ADEPT)), by Distribution Channel (Hospital...0 التعليقات 0 المشاركات 739 مشاهدة 0 معاينة
- Complete Monoclonal Antibodies Market Analysis & Forecast 2021-2028Growth Market Reports has included a latest report on the Global Monoclonal Antibodies Market into its archive of market research studies. The report is an amalgamation of detailed market overview based on the segmentations, applications, trends and opportunities, mergers and acquisitions, drivers, and restraints. The report showcases the current and forthcoming technical and financial details...0 التعليقات 0 المشاركات 1638 مشاهدة 0 معاينة
- Demand Discovery: Monoclonal Antibodies Market Research Techniques for Predicting Revenue StreamsThe global monoclonal antibodies market size was USD 204.42 billion in 2022 and is expected to register a revenue CAGR of 10.8% during the forecast period. Rising adoption in personalized medicine and precision therapies, expanding regulatory approvals of monoclonal antibodies by regulatory agencies across the globe, and increasing technological advancements in biotechnology and immunology are...0 التعليقات 0 المشاركات 1806 مشاهدة 0 معاينة
- Europe Monoclonal Antibodies Market Consumer TrendsMarket Introduction & Size Analysis: The global monoclonal antibodies market is projected to reach approximately US$729.4 billion by the end of 2031, up from US$276.9 billion in 2024, representing a robust CAGR of 12.4% from 2024 to 2031. This growth underscores the increasing importance of monoclonal antibodies within the biopharmaceutical sector. The Monoclonal antibodies (mAbs) market...0 التعليقات 0 المشاركات 443 مشاهدة 0 معاينة
- Global Monoclonal Antibodies Market to Achieve USD 65.23 billion by 2032Monoclonal Antibodies Market Drivers: The growing prominence of launching innovative treatment procedures, especially for targeted diseases, is attributed to leveraging the growth rate of the monoclonal antibodies market. In today’s world, people are more aware of seeking highly efficient treatment procedures at any cost, especially in developed countries. Chronic illnesses like diabetes,...0 التعليقات 0 المشاركات 206 مشاهدة 0 معاينة
- Cancer Biologics: The Forthcoming of Cancer TreatmentCancer Biologics: The Forthcoming of Cancer Treatment What are Cancer Biologics?Biologics, also known as biological drugs, are medicines produced from living organisms using biotechnology. In oncology, biologics are designed to target specific molecules involved in cancer growth and progression. Unlike traditional chemotherapy that targets all rapidly dividing cells, biologics work with...0 التعليقات 0 المشاركات 1216 مشاهدة 0 معاينة
- Cancer Immunotherapy Market is Slated to Witness Tremendous Growth in Coming Years: 2023-2028The Cancer Immunotherapy Market research study offers stakeholders in-depth insights into the dynamics of the market and its different fragmentations. This study provides stakeholders with comprehensive industry elements through detailed-driven information that is based on reliable, impartial, and accurate data. The study offers in-depth qualitative and quantitative insights on market...0 التعليقات 0 المشاركات 9441 مشاهدة 0 معاينة
- CD38 and Multiple Myeloma: Unleashing the Potential of Targeted TherapiesUnleashing the Potential: CD38 Directed Therapies Revolutionize Multiple Myeloma Treatment Introduction Multiple Myeloma is a complex and incurable hematologic malignancy characterized by the proliferation of abnormal plasma cells in the bone marrow. Despite advances in treatment, the disease remains challenging due to its heterogeneous nature and the development of drug resistance. Recent...0 التعليقات 0 المشاركات 548 مشاهدة 0 معاينة
- Exploring the Evolving Landscape of Multiple Myeloma Therapies MarketThe Changing Landscape of Multiple Myeloma Therapies The treatment landscape for Multiple Myeloma has been evolving rapidly, reflecting advancements in medical science and a better understanding of the disease's pathology. Multiple Myeloma, a malignancy of plasma cells in the bone marrow, presents significant treatment challenges due to its heterogeneous nature and variable...0 التعليقات 0 المشاركات 647 مشاهدة 0 معاينة
الصفحات المعززة